Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Integr Biol (Camb). 2013 Feb;5(2):414–422. doi: 10.1039/c2ib20161e

Figure 4. Pentoxifylline (PTX) effect on iRBC/uRBC dynamic deformabilities.

Figure 4

A. 100 μg/ml PTX was added to the RPMI cell culture medium containing 0.1 % hematocrit. After 4 h PTX incubation, the iRBC/uRBCs velocities with and without PTX treament were compared. B. 20 and 100 μg/ml PTX was added to the RPMI cell culure medium containing 0.1% hematocrit. After 4 h PTX incubation, the velocities of uRBCs treated with different PTX concentrations were compared. C. 100 μg/ml PTX was added to the RPMI cell culture medium containing 0.1% hematocrit. After 2, 4, and 6 h PTX incubation, the uRBC velocities at different test conditions were compared. D. iRBC velocities after 2, 4 and 6h PTX treatment were compared. No statistically significant change in iRBC velocity can be concluded. E. PTX-ART Combination effect on RBC deformability. No statistically significant difference can be concluded comparing RBCs treated with ART only versus cells treated with PTX-ART combinational therapy.